Literature DB >> 9066154

In vitro susceptibility of Trichophyton rubrum isolates to griseofulvin and tioconazole. Induction and isolation of a resistant mutant to both antimycotic drugs. Mutant of Trichophyton rubrum resistant to griseofulvin and tioconazole.

A L Fachin1, C M Maffei, N M Martinez-Rossi.   

Abstract

The in vitro susceptibility of three clinical Trichophyton rubrum isolates to griseofulvin and tioconazole, determined by the minimal inhibitory concentration (MIC), was 2 and 0.5 to 1.0 micrograms/ml, respectively. One mutant (gril) obtained after mutagenic treatment of one of these isolates was selected and showed simultaneous resistance to griseofulvin (MIC > 2000 micrograms/ml) and tioconazole (MIC = 1.0 microgram/ml). The clinical importance and the possibility of a multidrug resistance (MDR)-type mechanism being involved in this event is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9066154     DOI: 10.1007/bf00632334

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  14 in total

1.  The treatment of dermatomycoses with orally administered griseofulvin.

Authors:  H BLANK; F J ROTH
Journal:  AMA Arch Derm       Date:  1959-03

2.  Griseofulvin for the systemic treatment of dermatomycoses.

Authors:  H BLANK; J G SMITH; F J ROTH; N ZAIAS
Journal:  J Am Med Assoc       Date:  1959-12-19

3.  Susceptibility of Trichophyton rubrum to griseofulvin.

Authors:  R Scholz; W Meinhof
Journal:  Mycoses       Date:  1991 Sep-Oct       Impact factor: 4.377

Review 4.  The biochemistry of P-glycoprotein-mediated multidrug resistance.

Authors:  J A Endicott; V Ling
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

5.  Tioconazole nail solution--an open study of its efficacy in onychomycosis.

Authors:  R J Hay; R M Mackie; Y M Clayton
Journal:  Clin Exp Dermatol       Date:  1985-03       Impact factor: 3.470

6.  Antimitotic action of griseofulvin does not involve disruption of microtubules.

Authors:  L M Grisham; L Wilson; K G Bensch
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

Review 7.  Antifungal agents: an overview. Part II.

Authors:  A K Gupta; D N Sauder; N H Shear
Journal:  J Am Acad Dermatol       Date:  1994-06       Impact factor: 11.527

8.  Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene.

Authors:  R Ben-Yaacov; S Knoller; G A Caldwell; J M Becker; Y Koltin
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

Review 9.  Antifungal agents: an overview. Part I.

Authors:  A K Gupta; D N Sauder; N H Shear
Journal:  J Am Acad Dermatol       Date:  1994-05       Impact factor: 11.527

10.  Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance.

Authors:  F S Clark; T Parkinson; C A Hitchcock; N A Gow
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

View more
  12 in total

1.  Molecular markers reveal exclusively clonal reproduction in Trichophyton rubrum.

Authors:  Y Gräser; J Kühnisch; W Presber
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

2.  Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine.

Authors:  Pranab K Mukherjee; Steven D Leidich; Nancy Isham; Ingrid Leitner; Neil S Ryder; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Membrane transporters in self resistance of Cercospora nicotianae to the photoactivated toxin cercosporin.

Authors:  Aydin Beseli; Alongkorn Amnuaykanjanasin; Sonia Herrero; Elizabeth Thomas; Margaret E Daub
Journal:  Curr Genet       Date:  2015-04-11       Impact factor: 3.886

4.  Terbinafine resistance mediated by salicylate 1-monooxygenase in Aspergillus nidulans.

Authors:  Marcia A S Graminha; Eleusa M F Rocha; Rolf A Prade; Nilce M Martinez-Rossi
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

5.  Transcriptional profiling reveals the expression of novel genes in response to various stimuli in the human dermatophyte Trichophyton rubrum.

Authors:  Nalu T A Peres; Pablo R Sanches; Juliana P Falcão; Henrique C S Silveira; Fernanda G Paião; Fernanda C A Maranhão; Diana E Gras; Fernando Segato; Rodrigo A Cazzaniga; Mendelson Mazucato; Jeny R Cursino-Santos; Roseli Aquino-Ferreira; Antonio Rossi; Nilce M Martinez-Rossi
Journal:  BMC Microbiol       Date:  2010-02-08       Impact factor: 3.605

6.  Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.

Authors:  Anita Hryncewicz-Gwóźdź; Katarzyna Kalinowska; Ewa Plomer-Niezgoda; Jacek Bielecki; Tomasz Jagielski
Journal:  Mycopathologia       Date:  2013-04-18       Impact factor: 2.574

7.  RNA-sequencing analysis of Trichophyton rubrum transcriptome in response to sublethal doses of acriflavine.

Authors:  Gabriela Felix Persinoti; Nalu Teixeira de Aguiar Peres; Tiago Rinaldi Jacob; Antonio Rossi; Ricardo Zorzetto Vêncio; Nilce Maria Martinez-Rossi
Journal:  BMC Genomics       Date:  2014-10-27       Impact factor: 3.969

8.  Transcription of N- and O-linked mannosyltransferase genes is modulated by the pacC gene in the human dermatophyte Trichophyton rubrum.

Authors:  Niege S Mendes; Glauce L Trevisan; Aline H Silva Cruz; Rodrigo S Santos; Nalu T A Peres; Nilce M Martinez-Rossi; Antonio Rossi
Journal:  FEBS Open Bio       Date:  2012-09-28       Impact factor: 2.693

9.  Analysis of gene expression changes in Trichophyton rubrum after skin interaction.

Authors:  Tao Liu; Xingye Xu; Wenchuan Leng; Ying Xue; Jie Dong; Qi Jin
Journal:  J Med Microbiol       Date:  2014-02-28       Impact factor: 2.472

Review 10.  Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus.

Authors:  Nilce M Martinez-Rossi; Tamires A Bitencourt; Nalu T A Peres; Elza A S Lang; Eriston V Gomes; Natalia R Quaresemin; Maíra P Martins; Lucia Lopes; Antonio Rossi
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.